OH HB117

Establishes a statewide pilot program beginning July 1, 2018, providing long-acting opioid antagonist therapy (naltrexone or similar) to offenders convicted of opioid-related offenses who will be released on supervised release.

Applies to eligible offenders confined in state or local correctional facilities and community residential facilities for at least 30 days for opioid-related offenses, operating through December 31, 2020, with possible extension until June 30, 2023.

Requires participating offenders receive at least 30 days of therapy before release, with costs paid by the state during confinement and through Medicaid or other health insurance after release.

Mandates courts indicate in conviction records whether offenses relate to or resulted from opiate/opioid addiction, and requires facilities to inform eligible offenders of program benefits before release.

Makes noncompliance with post-release therapy terms and conditions established under the program a violation of supervised release, with Department of Rehabilitation and Correction to evaluate program success and report findings by January 1, 2020.